Treatment Moderators and Predictors of Outcome in the Treatment of Early Age Mania (TEAM) Study

Benedetto Vitiello1, Mark A. Riddle2, Gayane Yenokyan2, David A. Axelson3, Karen D. Wagner4, Paramjit Joshi5, John T. Walkup6, Joan Luby7, Boris Birmaher3, Neal D. Ryan3, Graham Emslie8, Adelaide Robb5, Rebecca Tillman7
1National Institute of Mental Health (NIMH)
2Johns Hopkins University
3University of Pittsburgh
4University of Texas at Galveston
5Children National Medical Center–George Washington University
6(Cornell University
7Washington University in St. Louis;
8University of Texas Southwestern Medical Center

Tài liệu tham khảo

McClellan, 2007, Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder, J Am Acad Child Adolesc Psychiatry, 46, 107, 10.1097/01.chi.0000242240.69678.c4 Liu, 2011, Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis, J Am Acad Child Adolesc Psychiatry, 50, 749, 10.1016/j.jaac.2011.05.011 Correll, 2010, Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials, Bipolar Disord, 12, 116, 10.1111/j.1399-5618.2010.00798.x Kraemer, 2002, Mediators and moderators of treatment effects in randomized clinical trials, Arch Gen Psychiatry, 59, 877, 10.1001/archpsyc.59.10.877 Perlis, 2010, Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study, J Clin Psychiatry, 71, 296, 10.4088/JCP.09m05514yel DelBello, 2007, Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode, Am J Psychiatry, 164, 582, 10.1176/ajp.2007.164.4.582 Birmaher, 2009, Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study, Am J Psychiatry, 166, 795, 10.1176/appi.ajp.2009.08101569 Masi, 2010, Pharmacological response in juvenile bipolar disorder subtypes: a naturalistic retrospective examination, Psychiatry Res, 177, 192, 10.1016/j.psychres.2009.01.022 Wagner, 2009, Divalproex treatment effect not influenced by age (10–13 versus 14–17) in placebo controlled trial (4 weeks) in mania, J Am Acad Child Adolesc Psychiatry, 48, 519, 10.1097/CHI.0b013e31819c55ec Geller, 2012, A randomized controlled trial of risperidone, lithium, or divalproex for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents, Arch Gen Psychiatry, 69, 515, 10.1001/archgenpsychiatry.2011.1508 Cipriani, 2011, Comparative effectiveness and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, Lancet, 378, 1306, 10.1016/S0140-6736(11)60873-8 Geller, 2002, Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype, Am J Psychiatry, 159, 927, 10.1176/appi.ajp.159.6.927 Spearing, 1997, Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP, Psychiatry Res, 73, 159, 10.1016/S0165-1781(97)00123-6 Axelson, 2003, A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents, J Child Adolesc Psychopharmacol, 13, 463, 10.1089/104454603322724850 Duke, 1980, Adolescents' self-assessment of sexual maturation, Pediatrics, 66, 918, 10.1542/peds.66.6.918 Andreasen, 1977, The family history method using diagnostic criteria, Arch Gen Psychiatry, 34, 1229, 10.1001/archpsyc.1977.01770220111013 Puigh-Antich, 1986 Geller, 2000, Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype, J Am Acad Child Adolesc Psychiatry, 39, 1543, 10.1097/00004583-200012000-00018 Lachin, 1999, Worst-rank score analysis with informatively missing observations in clinical trials, Control Clin Trials, 20, 408, 10.1016/S0197-2456(99)00022-7 Zou, 2004, A modified Poisson regression approach to prospective studies with binary data, Am J Epidemiol, 159, 702, 10.1093/aje/kwh090 Rosnow, 2000, Contrasts and correlations in effect-size estimation, Psychol Sci, 11, 446, 10.1111/1467-9280.00287 Feaster, 2011, Modeling site effects in the design and analysis of multi-site trials, Am J Drug Alcohol Abuse, 37, 383, 10.3109/00952990.2011.600386 Kraemer, 2000, Pitfalls of multisite randomized clinical trials of efficacy and effectiveness, Schizophr Bull, 26, 533, 10.1093/oxfordjournals.schbul.a033474 Spirito, 2009, Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in Adolescents, J Consult Clin Psychol, 77, 439, 10.1037/a0014834 Leibenluft, 2011, Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths, Am J Psychiatry, 168, 129, 10.1176/appi.ajp.2010.10050766 McKay, 2006, Psychiatrist effects in the psychopharmacological treatment of depression, J Affect Dis, 92, 287, 10.1016/j.jad.2006.01.020